Volume 25, Number 3—March 2019
Research
Increased Risk for Invasive Group A Streptococcus Disease for Household Contacts of Scarlet Fever Cases, England, 2011–2016
Table 2
Year | No. scarlet fever cases | Estimated no. contacts | No. iGAS cases in contacts† | Attack rate/100,000 person-years (95% CI) | Background iGAS incidence/100,000 person-years | Rate ratio (95% CI) |
---|---|---|---|---|---|---|
2011 |
3,128 |
8,929 |
0 |
0.0 (0.0–251.5) |
2.29 |
NA |
2012 |
4,632 |
13,073 |
0 |
0.0 (0.0–171.8) |
2.35 |
NA |
2013 |
5,204 |
14,778 |
0 |
0.0 (0.0–152.0) |
2.99 |
NA |
2014 |
16,394 |
47,015 |
3 |
38.8 (8.0–113.5) |
2.29 |
16.9 (5.5–52.6) |
2015 |
18,022 |
51,454 |
3 |
35.5 (7.3–103.7) |
3.48 |
10.2 (3.3–31.7) |
2016 |
18,811 |
54,435 |
5 |
55.9 (18.2–130.5) |
3.91 |
14.3 (5.9–34.7) |
Total | 66,191 | 189,684 | 11 | 35.3 (17.6–63.2) | 2.89 | 12.2 (6.7–22.1) |
*iGAS, invasive group A Streptococcus infection; NA, not applicable.
†During the 60 days after onset of scarlet fever in the household.
Page created: February 19, 2019
Page updated: February 19, 2019
Page reviewed: February 19, 2019
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.